Healthcare provider profile · identity verified

Sondra Aiken, MD

Internal Medicine · MANOR, TX · NPI 1073750352

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	727	238
Rosuvastatin Calcium	Rosuvastatin Calcium	516	187
Amlodipine Besylate	Amlodipine Besylate	497	168
Losartan Potassium	Losartan Potassium	468	159
Levothyroxine Sodium	Levothyroxine Sodium	367	111
Metformin Hcl	Metformin Hcl	338	114
Gabapentin	Gabapentin	293	112
Lisinopril	Lisinopril	278	97
Omeprazole	Omeprazole	273	103
Alprazolam	Alprazolam	263	76
Ozempic	Semaglutide	204	35
Atenolol	Atenolol	193	59
Metoprolol Succinate	Metoprolol Succinate	192	69
Nifedipine Er	Nifedipine	185	64
Albuterol Sulfate Hfa	Albuterol Sulfate	174	73
Amlodipine-Valsartan	Amlodipine Besylate/Valsartan	170	57
Hydrochlorothiazide	Hydrochlorothiazide	167	57
Clopidogrel	Clopidogrel Bisulfate	164	55
Pantoprazole Sodium	Pantoprazole Sodium	164	60
Eliquis	Apixaban	155	43
Metoprolol Tartrate	Metoprolol Tartrate	146	54
Metformin Hcl Er	Metformin Hcl	142	51
Simvastatin	Simvastatin	142	45
Tamsulosin Hcl	Tamsulosin Hcl	140	53
Carvedilol	Carvedilol	133	44
Fluticasone Propionate	Fluticasone Propionate	131	55
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	127	43
Candesartan Cilexetil	Candesartan Cilexetil	126	40
Famotidine	Famotidine	126	55
Glipizide	Glipizide	119	38
Jardiance	Empagliflozin	116	43
Glipizide Er	Glipizide	113	38
Montelukast Sodium	Montelukast Sodium	110	44
Donepezil Hcl	Donepezil Hcl	108	35
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	100	38
Prednisone	Prednisone	98	65
Furosemide	Furosemide	94	37
Tramadol Hcl	Tramadol Hcl	93	31
Zolpidem Tartrate	Zolpidem Tartrate	92	26
Temazepam	Temazepam	83	23
Trazodone Hcl	Trazodone Hcl	80	28
Triamcinolone Acetonide	Triamcinolone Acetonide	79	53
Ketoconazole	Ketoconazole	78	41
Ezetimibe	Ezetimibe	77	27
Lorazepam	Lorazepam	72	15
Pregabalin	Pregabalin	68	26
Sertraline Hcl	Sertraline Hcl	67	20
Tizanidine Hcl	Tizanidine Hcl	67	37
Valsartan	Valsartan	66	26
Januvia	Sitagliptin Phosphate	65	18
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	64	21
Pravastatin Sodium	Pravastatin Sodium	62	20
Allopurinol	Allopurinol	61	21
Escitalopram Oxalate	Escitalopram Oxalate	60	24
Glipizide-Metformin	Glipizide/Metformin Hcl	60	21
Tresiba Flextouch U-100	Insulin Degludec	58	19
Azithromycin	Azithromycin	54	52
Latanoprost	Latanoprost	52	15
Meloxicam	Meloxicam	51	32
Diclofenac Sodium	Diclofenac Sodium	50	31
Pioglitazone Hcl	Pioglitazone Hcl	50	20
Potassium Chloride	Potassium Chloride	50	22
Clonazepam	Clonazepam	49	suppressed
Meclizine Hcl	Meclizine Hcl	47	26
Folic Acid	Folic Acid	45	13
Rybelsus	Semaglutide	45	19
Chlorthalidone	Chlorthalidone	43	17
Lovastatin	Lovastatin	43	15
Naproxen	Naproxen	43	24
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	41	19
Spironolactone	Spironolactone	40	16
Tadalafil	Tadalafil	40	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	39	38
Acetaminophen-Codeine	Acetaminophen With Codeine	38	21
Clonidine Hcl	Clonidine Hcl	38	17
Finasteride	Finasteride	38	14
Myrbetriq	Mirabegron	37	suppressed
Sildenafil Citrate	Sildenafil Citrate	36	13
Trulicity	Dulaglutide	36	suppressed
Nystatin	Nystatin	35	21
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	35	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	34	31
Tradjenta	Linagliptin	34	11
Memantine Hcl	Memantine Hcl	33	12
Ammonium Lactate	Ammonium Lactate	30	15
Duloxetine Hcl	Duloxetine Hcl	30	15
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	30	12
Xarelto	Rivaroxaban	30	suppressed
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	29	suppressed
Benzonatate	Benzonatate	28	16
Acyclovir	Acyclovir	27	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	27	suppressed
Mupirocin	Mupirocin	27	24
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	27	14
Ciprofloxacin Hcl	Ciprofloxacin Hcl	26	23
Methylprednisolone	Methylprednisolone	26	22
Atenolol-Chlorthalidone	Atenolol/Chlorthalidone	25	suppressed
Celecoxib	Celecoxib	25	11
Hydralazine Hcl	Hydralazine Hcl	25	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	25	11
Paxlovid	Nirmatrelvir/Ritonavir	25	25
Glimepiride	Glimepiride	24	suppressed
Dexlansoprazole Dr	Dexlansoprazole	22	suppressed
Ibuprofen	Ibuprofen	22	12
Alendronate Sodium	Alendronate Sodium	21	suppressed
Benazepril Hcl	Benazepril Hcl	21	suppressed
Citalopram Hbr	Citalopram Hydrobromide	21	suppressed
Paroxetine Hcl	Paroxetine Hcl	21	suppressed
Brimonidine Tartrate-Timolol	Brimonidine Tartrate/Timolol	20	suppressed
Buspirone Hcl	Buspirone Hcl	20	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	20	suppressed
Irbesartan	Irbesartan	20	suppressed
Oseltamivir Phosphate	Oseltamivir Phosphate	20	19
Aripiprazole	Aripiprazole	19	suppressed
Diazepam	Diazepam	19	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	19	19
Novolog Flexpen	Insulin Aspart	19	suppressed
Propranolol Hcl	Propranolol Hcl	19	suppressed
Valacyclovir	Valacyclovir Hcl	19	suppressed
Bupropion Xl	Bupropion Hcl	18	suppressed
Cephalexin	Cephalexin	18	16
Dicyclomine Hcl	Dicyclomine Hcl	18	suppressed
Entresto	Sacubitril/Valsartan	18	suppressed
Synthroid	Levothyroxine Sodium	18	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	18	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	17	suppressed
Azelastine Hcl	Azelastine Hcl	17	suppressed
Ciclopirox	Ciclopirox	17	suppressed
Humalog Mix 75-25 Kwikpen	Insulin Lispro Protamin/Lispro	17	suppressed
Mirtazapine	Mirtazapine	17	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	17	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	17	suppressed
Bumetanide	Bumetanide	16	suppressed
Levetiracetam	Levetiracetam	16	suppressed
Nebivolol Hcl	Nebivolol Hcl	16	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	16	suppressed
Warfarin Sodium	Warfarin Sodium	16	suppressed
Amoxicillin	Amoxicillin	15	14
Breo Ellipta	Fluticasone/Vilanterol	15	suppressed
Labetalol Hcl	Labetalol Hcl	15	suppressed
Mounjaro	Tirzepatide	15	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	15	suppressed
Amlodipine-Olmesartan	Amlodipine Bes/Olmesartan Med	14	suppressed
Colchicine	Colchicine	14	suppressed
Estradiol	Estradiol	14	suppressed
Hydrocortisone	Hydrocortisone	14	11
Hydroxyzine Hcl	Hydroxyzine Hcl	14	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	14	suppressed
Bupropion Hcl Sr	Bupropion Hcl	13	suppressed
Isentress	Raltegravir Potassium	13	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	13	suppressed
Ondansetron Hcl	Ondansetron Hcl	13	11
Darunavir	Darunavir	12	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	12	suppressed
Etravirine	Etravirine	12	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	12	suppressed
Ipratropium Bromide	Ipratropium Bromide	12	suppressed
Ondansetron Odt	Ondansetron	12	suppressed
Symbicort	Budesonide/Formoterol Fumarate	12	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	12	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	12	suppressed
Breyna	Budesonide/Formoterol Fumarate	11	suppressed
Candesartan-Hydrochlorothiazid	Candesartan/Hydrochlorothiazid	11	suppressed
Chlorhexidine Gluconate	Chlorhexidine Gluconate	11	suppressed
Methimazole	Methimazole	11	suppressed
Primidone	Primidone	11	suppressed
Tresiba Flextouch U-200	Insulin Degludec	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error